<HTML lang="en" dir="ltr" class="client-nojs">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki ltr sitedir-ltr ns-0 ns-subject page-Team_Vilnius-Lithuania-OG_Model skin-igem action-view"><DIV id="globalWrapper"><DIV id="content" class="mw-body" role="main"><DIV id="top_title"><H1 id="firstHeading" class="firstHeading"><SPAN dir="auto">Team:Vilnius-Lithuania-OG/Model</SPAN></H1></DIV></DIV></DIV><TITLE>Collaborations</TITLE><DIV id="" class="clearfix"><HEADER id="header" class="page-section full-header"><DIV id="header-wrap" style="padding-left:1%"><DIV class="clearfix"><NAV id="primary-menu"><UL><LI id="homeheader"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG">Home</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Overview">Project</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Overview">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Design">Design</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Design_Regulatory">Design for Regulatory Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Model">Modelling</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Results">Results</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Demonstrate">Proof of Concept</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Measurement">Measurement</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Improve">Improve</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Nucleotide_Design">Substrate Design Prospects</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Entrepreneurship">Entrepreneurship</A></LI></UL><LI id="softwareh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Software">Software</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Software">Motivation</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Gan_Introduction">Generative Adversarial Network â€“ GAN</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/ProteinGAN">Protein GAN</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/ReactionGAN">Reaction GAN</A></LI><LI id="partsh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts">Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts">Overview</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-basic">Basic Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-composite">Composite Parts</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Parts#section-collection">Collection</A></LI><LI id="notebookh"><A href="/pages/notebook/index.html">Notebook</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/catseqguide">Using the CAT-Seq</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/labnotebook">Lab Journal</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/InterLab">Interlab</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Safety">Safety</A></LI><LI id="humanh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Human_Practices">Human practices</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Human_Practices">Human Practices</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Public_Engagement">Education and Public Engagement</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Collaborations">Collaborations</A></LI><LI id="peopleh"><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/People">People</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/People">Team</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Attributions">Attributions</A></LI><LI><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Sponsors">Sponsors</A></LI></NAV></DIV></DIV></HEADER><SECTION id="slider" class="slider-element slider-parallax full-screen force-full-screen with-header swiper_wrapper page-section clearfix"><DIV class="slider-parallax-inner"><DIV class="swiper-container swiper-parent"><DIV class="swiper-wrapper"><DIV class="swiper-slide" style="background-image: url('https://static.igem.org/mediawiki/2018/5/52/T--Vilnius-Lithuania-OG--model2.jpg');"><DIV class="container clearfix"><DIV class="slider-caption slider-caption-center"><H2 data-caption-animate="fadeInUp" style="color:aliceblue">MODELS</H2></DIV></DIV></DIV></DIV></DIV></DIV></SECTION><DIV id="page-menu"><DIV id="page-menu-wrap"><DIV class="container clearfix"><DIV class="menu-title">Explore <SPAN>MODELS</SPAN></DIV><NAV class="one-page-menu"><UL><LI><A href="#" data-href="#section-droplet">Droplet coalescence</A></LI><LI><A href="#" data-href="#section-mutant">In-silico mutant determination</A></LI><LI><A href="#" data-href="#section-inhibitory">Modified nucleotide inhibitory effect</A></LI></UL></NAV></DIV></DIV></DIV><SECTION style="overflow:hidden; position:relative; background-color: #FFF;"><DIV class="content-wrap"><DIV class="single-post nobottommargin"><DIV class="container clearfix"><DIV class="tekstodydis"><P>During the development of CAT-Seq we have developed three different in-depth mathematical models that have immensely helped us create a well-working system.</P><SECTION id="section-droplet" class="page-section"><DIV class="fancy-title title-border-color"><H2>Mathematical description of droplet coalescence</H2></DIV><P>Efficient reaction mix enrichment by droplet merging was an extremely important aspect of CAT-Seq as it is directly responsible for the accuracy and information retainment degree. Yet, the droplet merging was immensely inefficient, as droplet coalescence techniques contain multiple parameters that requires precise tuning. For that reason we have developed an in-depth mathematical description of the droplet merging. Explore the model by <SPAN><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Merging_Model"> clicking here</A></SPAN>.</P><SECTION id="section-mutant" class="page-section"><DIV class="fancy-title title-border-color"><H2>In-silico determination of Esterase mutants</H2></DIV><P>In order to assess the CAT-Seq accuracy and precision, using in-silico methods we have derived CAT-Seq esterase mutants which had different activities, which would be later used for Catalytic Activity Sequencing performance benchmarking. Explore the model by <SPAN><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/MutationModel"> clicking here</A></SPAN>.</P><SECTION id="section-inhibitory" class="page-section"><DIV class="fancy-title title-border-color"><H2>Modified Nucleotide inhibitory effect model</H2></DIV><P>While researching the literature we have found out that modified nucleotides (which we are using as substrate nucleotides) might sometimes affect the amplification efficiency of Phi29 polymerase. We were concerned by that fact because the amplification efficiency was important for us, as nanopore sequence requires long amplicons. For this reason we have derived a mathematical model to assess the modified nucleotide inhibitory effects on the DNA amplicon length. <SPAN><A href="https://2018.igem.org/Team:Vilnius-Lithuania-OG/Inhibition_Model"> clicking here</A></SPAN>.</P></SECTION></SECTION></SECTION></DIV></DIV></DIV></DIV></SECTION></DIV></BODY></HTML>